For decades, there has been inadequate liability insurance for commercial vehicles. This means that if there is a catastrophic accident caused by a commercial vehicle crash, it has a negative impact on Social Security and Medicare. According to congressman Matt Cartwright of Pennsylvania, there is good news on this front. Continue reading
Dr. Robert Pedowitz, former chairman of the orthopedic surgery department at the University of California, Los Angeles, will receive $10 million to settle his whistleblower lawsuit against the institution for alleged financial conflicts of interest. Dr. Pedowitz joined the department in 2009, and stepped down as chair the following year after complaining about conflicts of interest and financial ties between industry and doctors. In 2011, he resigned and filed a whistleblower-retaliation lawsuit. The suit was settled on Tuesday in the Los Angeles County Superior Court without the institution admitting wrongdoing. Pedowitz named the University of California, Los Angeles, the UC regents, fellow surgeons and senior university officials in the lawsuit. Continue reading
The U.S. Food and Drug Administration just announced that injectable corticosteroids must now contain a label warning concerning increased adverse events associated with epidural injections
Risks include death, stroke, permanent blindness, and permanent paralysis, the FDA indicated, according to MedPage Today. The warning followed an agency review of a number of reports in both the FDA Adverse Event Reporting System (FAERS) database and medical literature. In its warning, the FDA indicated that, “Serious adverse events included death, spinal cord infarction, paraplegia, quadriplegia, cortical blindness, stroke, seizures, nerve injury, and brain edema.” Continue reading
The U.S. Food and Drug Administration (FDA) is expected to issue its first regulations on electronic cigarettes by the end of the month, NBC reports; many health experts are awaiting what the regulations will say. Many would like the new rules will strictly limit the e-cigarettes, which have brought up concerns among some who think they keep smokers addicted rather than help them quit, but are realistic about the actual outcome. Continue reading
The U.S. Food and Drug Administration is proposing a new program that would give earlier access to certain high-risk medical devices, but some are saying that the approach only benefits medical device companies. According to HealthData Management, the agency is seeking public comment on the proposal and is touting it as a “collaborative approach to facilitate product development under the agency’s existing regulatory authorities” that “seeks to reduce the time associated with product development” instead of current programs that have “focused on reducing the time for the premarket review.” Continue reading
New research suggests that patients with HIV using protease inhibitor regimens long term may have a higher risk of diabetes. The study, published in Diabetic Medicine, found that the HIV infection by itself does not seem to increase the risk of diabetes, however. Continue reading
A jury has awarded a man nearly $4 million in damages over an incorrect diagnosis and unnecessary surgery.
The man says he was disabled and is sick following treatments by neurologist Dr. Dale Lange, according to CBS New York. “I went through a lot of unnecessary stuff; a lot of pain; eventually lost my wife and family over all this—and I’m like, you know what? He did me wrong,” he said. Continue reading
Otter Products LLC, the company that makes OtterBox smartphone and tablet cases, has settled a whistleblower lawsuit alleging that the company violated federal law by underpaying customs duties, North Colorado Business Report reports. According to U.S. Attorney John Walsh’s office, the company has paid $4.3 million to the U.S. government. The statement was announced Monday by the U.S. Attorney’s Office for the District of Colorado, Department of Homeland Security and U.S. Customs and Border Protection. Continue reading
Generic drugs, non-name brand medications that cost far less than the brand-name, came under greater scrutiny recently after the U.S. Food and Drug Administration (FDA) banned imports of treatments made from two Indian facilities (Ranbaxy Labs and Wockhardy Ltd). The agency was forced to halt sale of generic drugs from these facilities due to drug safety. This spurred fear in the FDA and consumers alike, who are less likely to take generic drugs if they develop a reputation for being dangerous-even if they safe and just as effective. Generic medications make up nearly 80 percent of US prescriptions. Continue reading
A partially paralyzed man claims that Delta Airlines workers forced him to crawl on and off two flights in 2012. The lawsuit, brought in 2013, has just been settled.
The Maui man sued Delta over allegations that airline workers forced him to crawl on and off the flights the prior year and that the airline did not provide a wheelchair or other assistance on either of the 2012 flights, according to the Associated Press (AP). Continue reading